The RET proto-oncogene, a transmembrane tyrosine kinase receptor, is i
nvolved in the development of at least five different disease phenotyp
es. RET is activated through somatic rearrangements in a number of cas
es of papillary thyroid carcinoma while germ-line point mutations are
associated with three inherited cancer syndromes MEN 2A, MEN 2B and FM
TC. Moreover, point mutations or heterozygous deletions of RET are fou
nd in the dominant form of Hirschsprung disease or congenital colonic
aganglionosis. We cloned the entire RET genomic sequence in a contig o
f cosmids encompassing 150 kb, from the CA repeat sTCL-2 to the region
upstream the RET promoter, and established the position of the 20 exo
ns of the RET gene with respect to a detailed restriction map based on
eight endonucleases. A new highly polymorphic CA repeat sequence was
identified within intron 5 of RET (RET-INT5). Finally the orientation
of RET on chromosome 10q11.2 made it possible to orientate three other
genes rearranged with RET in papillary thyroid carcinomas, namely H4/
D10S170 on 10q21, R1 alpha on 17q23 and RFG2/Ele1 on 10q11.2.